KUKJEON PHARMACEUTICAL Co.,Ltd Logo

KUKJEON PHARMACEUTICAL Co.,Ltd

Develops and manufactures APIs and chemical materials for the electronics industry.

307750 | KO

Overview

Corporate Details

ISIN(s):
KR7307750000
LEI:
Country:
South Korea
Address:
경기도 안양시 동안구 학의로 282 B동 1516호 (관양동,금강펜테리움), 안양시

Description

KUKJEON PHARMACEUTICAL Co., Ltd. is a chemical total solution provider specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs). The company's portfolio includes raw materials for specialized medicines such as choline alfoscerates, benfothiamines, and napamostat. A key product is Itopride hydrochloride, a functional indigestion treatment, for which the company holds a proprietary manufacturing patent. In addition to its pharmaceutical focus, the company also develops and supplies chemical materials for the electronics industry.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2026-01-14 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 134.4 KB
2026-01-05 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 134.5 KB
2025-12-22 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 134.9 KB
2025-09-16 00:00
전환사채(해외전환사채포함)발행후만기전사채취득
Korean HTML 12.2 KB
2025-09-04 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 132.8 KB
2025-08-27 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 132.7 KB
2025-08-19 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 134.5 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean HTML 1.3 MB
2025-08-06 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 132.7 KB
2025-07-22 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 133.1 KB
2025-07-07 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 135.0 KB
2025-06-20 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 143.5 KB
2025-06-16 00:00
전환사채(해외전환사채포함)발행후만기전사채취득
Korean HTML 11.7 KB
2025-06-11 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 139.7 KB
2025-06-02 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 138.9 KB

Automate Your Workflow. Get a real-time feed of all KUKJEON PHARMACEUTICAL Co.,Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KUKJEON PHARMACEUTICAL Co.,Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KUKJEON PHARMACEUTICAL Co.,Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.